PBC News
-
City of Phoenix makes pitch as emerging life science hub to the world at BIO International
A delegation of leaders from the city of Phoenix and members of the Phoenix Bioscience Core community visited San Diego this week for BIO International 2022, the world’s largest convening […]
-
PBC Company Calviri announces enrollment of 800 dogs in preventative cancer vaccine trial
Vaccine Against Canine Cancer Study (VACCS), with 800 dogs, making it the largest interventional canine clinical trial in the history of veterinary medicine.
-
TGen-Temple review suggests even normal weight individuals are susceptible to severe fatty liver disease
Severe fatty liver disease is commonly associated with obesity, but according to a review of scientific literature conducted by researchers at Temple University and the Translational Genomics Research Institute (TGen), an […]
-
Calviri CEO Dr. Stephen Johnston on cancer eradication
Phoenix Bioscience Core-based Calviri Inc.’s founder Dr. Stephen Johnston recently spoke to Progress, Potential and Possibilities on eradicating cancer via a universival preventative cancer vaccine.
-
TGen study allows late-stage cancer patients to use their health data to guide care
A unique study pairing researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, with one cancer patient is now underway to help answer that question. Rick Stanton, a former engineer and advanced prostate cancer patient, is at the center of TGen’s Patient Engagements, Operational Practices, and Laboratory Environment Standardization (PEOPLES) protocol.
-
Phoenix Mayor Kate Gallego discusses Phoenix Bioscience Core, growth of life science industry in Phoenix
Development Director Christine Mackay recently spoke to Arizona PBS about the growth of the Phoenix Bioscience Core and the city’s life science industry as a whole. Speaking to Arizona Horizon, Mayor Gallego noted how Phoenix has become a hot spot for life science companies from around the world.
-
UArizona Health Sciences previews new Center for Advanced Molecular and Immunological Therapies in Phoenix
The University of Arizona offered a new preview of the Center for Advanced Molecular and Immunological Therapies on May 16 as part of its Tomorrow is Here lecture series. The […]
-
Slideshow: Wexford Science + Technology plans new innovation labs at 850 PBC
Wexford Science & Technology, LLC, a national innovation district developer that partners exclusively with universities, academic medical centers, and research institutions, is launching the Wexford Innovation Labs at 850 PBC, the firm’s newest development located in the Phoenix Bioscience Core.
-
ASU names Marisa Domino to lead Center for Health Information and Research
ASU announced Marisa Domino will lead the Center for Health Information and Research in ASU’s College of Health Solutions on the downtown Phoenix campus.
-
Arizona Medical Association welcomes Dr. Jennifer Hartmark-Hill as 131st President
Got any book recommendations?